HG-1429

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1429

Drug Alias NameTREM2 modulator (Human Genome Sciences)Trem2a/2b/2c modulator (Human Genome Sciences)triggering receptor expressed on myeloid cells 2 modulator (Human Genome Sciences)HMAAD57 modulator (Human Genome Sciences)HG-1429

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTriggering receptor expressed on myeloid cells 2 modulators

TargetsTriggering receptor expressed on myeloid cells 2

Therapy Area/IndicationsImmune System DiseasesBone Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsImmune System DiseasesBone Diseases

Other Information

ATC CodeN/A